Koyfin Home > Directory > Health Care > Incyte Corp > Cost of Goods Sold

Incyte Corp Cost of Goods Sold Chart (INCY)

Incyte Corp annual/quarterly Cost of Goods Sold from 1993 to 2018.
  • Incyte Corp Cost of Goods Sold for the quarter ending December 12, 2018 was $331m a 2.84% increase of 9m year over year
  • Incyte Corp Cost of Goods Sold for the last 12 months ending December 12, 2018 was $1,292m a -0.02% decrease of 0m year over year
  • Incyte Corp Annual Cost of Goods Sold for 2018 was $1,292m a -7.88% decrease of -102m from 2017
  • Incyte Corp Annual Cost of Goods Sold for 2017 was $1,394m a 54.08% increase of 754m from 2016
  • Incyte Corp Annual Cost of Goods Sold for 2016 was $640m a 20.87% increase of 134m from 2015
Other Income Statement Metrics:
  • Incyte Corp EBITDA for the quarter ending December 12, 2018 was $103m a 145.94% increase of 150m year over year
  • Incyte Corp Net Income for the quarter ending December 12, 2018 was $69m a 159.57% increase of 110m year over year
  • Incyte Corp Total Revenue for the quarter ending December 12, 2018 was $528m a 27.65% increase of 146m year over year
View Chart On Koyfin

Quarterly INCY Cost of Goods Sold Data

12/2018$331m
09/2018$317m
06/2018$323m
03/2018$321m
12/2017$469m
09/2017$280m
06/2017$222m
03/2017$423m
12/2016$181m
09/2016$163m

Annual INCY Cost of Goods Sold Data

2018$1,292m
2017$1,394m
2016$640m
2015$506m
2014$351m
2013$261m
2012$211m
2011$179m
2010$124m
2009$119m